Metrics

Reasons why access cannot be provided (enquiries for Lilly studies)

Reason	Number of studies
Request is for non-Lilly study	13
Study with low enrollment, therefore, anonymisation of the data is not feasible	10
Medicine not approved	47
Study data not readily available due to the age of the study	4
Unapproved indication	19
Compound was sold to another company	1
Data are the property of an academic organization who did not agree to share the data due to the informed consent not providing information explaining the additional use of data to patients in the study	2
Out of scope per Sponsor Specific Information	17

Proposal number	Study Sponsor(s)/funder(s)	Reason(s)
615	GSK	The Research Proposal is not seeking access to anonymised patient level data
618	GSK	The Research Proposal is not seeking access to anonymised patient level data
633	GSK	The Research Proposal is not seeking access to anonymised patient level data
690	GSK	The Research Proposal is not seeking access to anonymised patient level data
931	BI/GSK	The Research Proposal did not meet the Sponsor policies for informed consent
938	BI/GSK/Roche	The Research Proposal is not seeking access to anonymised patient level data
941	Roche	The Research Proposal is not seeking access to anonymised patient level data
1047	GSK	The Research Proposal is not seeking access to anonymised patient level data
1087	GSK	The Research Proposal is not seeking access to anonymised patient level data
1107	GSK	The Research Proposal is not seeking access to anonymised patient level data
1552	Novartis	The proposed research required data that was not collected in the studies requested
1235	BI	The Research Proposal competes with the Sponsor's publication plan
1245	BI	The Research Proposal competes with the Sponsor's publication plan
1589	Novartis	The Research Proposal is not seeking access to anonymised patient level data